PL372900A1 - Treatment of metabolic syndrome - Google Patents
Treatment of metabolic syndromeInfo
- Publication number
- PL372900A1 PL372900A1 PL03372900A PL37290003A PL372900A1 PL 372900 A1 PL372900 A1 PL 372900A1 PL 03372900 A PL03372900 A PL 03372900A PL 37290003 A PL37290003 A PL 37290003A PL 372900 A1 PL372900 A1 PL 372900A1
- Authority
- PL
- Poland
- Prior art keywords
- treatment
- metabolic syndrome
- metabolic
- syndrome
- Prior art date
Links
- 208000001145 Metabolic Syndrome Diseases 0.000 title 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0209642A GB0209642D0 (en) | 2002-04-26 | 2002-04-26 | Metabolic syndrome |
GB0218912A GB0218912D0 (en) | 2002-08-14 | 2002-08-14 | Metabolic syndrome |
Publications (1)
Publication Number | Publication Date |
---|---|
PL372900A1 true PL372900A1 (en) | 2005-08-08 |
Family
ID=29272006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL03372900A PL372900A1 (en) | 2002-04-26 | 2003-04-24 | Treatment of metabolic syndrome |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1499357A1 (en) |
JP (1) | JP2005523915A (en) |
KR (1) | KR20040101545A (en) |
CN (1) | CN1646167A (en) |
AU (1) | AU2003227683A1 (en) |
BR (1) | BR0309375A (en) |
CA (1) | CA2483005A1 (en) |
IL (1) | IL164670A0 (en) |
MX (1) | MXPA04010544A (en) |
PL (1) | PL372900A1 (en) |
WO (1) | WO2003090784A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2016101363A (en) * | 2010-02-08 | 2018-11-21 | Прэари Фармасьютикалз, Ллк | METHOD FOR TREATING DISEASES ASSOCIATED WITH Glucocorticoid Insensitivity |
-
2003
- 2003-04-24 JP JP2003587413A patent/JP2005523915A/en active Pending
- 2003-04-24 AU AU2003227683A patent/AU2003227683A1/en not_active Abandoned
- 2003-04-24 WO PCT/EP2003/004357 patent/WO2003090784A1/en not_active Application Discontinuation
- 2003-04-24 MX MXPA04010544A patent/MXPA04010544A/en active IP Right Grant
- 2003-04-24 CA CA002483005A patent/CA2483005A1/en not_active Abandoned
- 2003-04-24 KR KR10-2004-7016843A patent/KR20040101545A/en not_active Application Discontinuation
- 2003-04-24 EP EP03725104A patent/EP1499357A1/en not_active Withdrawn
- 2003-04-24 PL PL03372900A patent/PL372900A1/en not_active Application Discontinuation
- 2003-04-24 CN CNA038088312A patent/CN1646167A/en active Pending
- 2003-04-24 BR BR0309375-1A patent/BR0309375A/en not_active IP Right Cessation
-
2004
- 2004-10-18 IL IL16467004A patent/IL164670A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR0309375A (en) | 2005-03-29 |
JP2005523915A (en) | 2005-08-11 |
CA2483005A1 (en) | 2003-11-06 |
AU2003227683A1 (en) | 2003-11-10 |
EP1499357A1 (en) | 2005-01-26 |
KR20040101545A (en) | 2004-12-02 |
WO2003090784A1 (en) | 2003-11-06 |
MXPA04010544A (en) | 2005-08-16 |
IL164670A0 (en) | 2005-12-18 |
CN1646167A (en) | 2005-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL218909A0 (en) | Treatment of diabetes | |
GB0201850D0 (en) | Therapeutic treatment | |
GB0216321D0 (en) | Therapeutic treatment | |
IL164266A0 (en) | Treatment of gastroparesis | |
GB0201674D0 (en) | Medical treatment | |
HK1078784A1 (en) | Therapeutic treatment | |
GB0223367D0 (en) | Therapeutic treatment | |
GB0218879D0 (en) | Medical treatment | |
GB0213869D0 (en) | The treatment of pain | |
GB0210464D0 (en) | Therapeutic treatment | |
GB0210741D0 (en) | Methods of therapy | |
GB0221157D0 (en) | Novel treatment | |
GB0217493D0 (en) | Novel methods of treatment | |
IL164951A0 (en) | The treatment of pain with lfendropil | |
EP1573063A4 (en) | Treatment of liver deseases | |
PL372900A1 (en) | Treatment of metabolic syndrome | |
GB0221712D0 (en) | Methods of treatment | |
IL172528A0 (en) | Surface treatment of sars-infected lungs | |
GB0203328D0 (en) | Substrate treatment | |
GB0329357D0 (en) | Treatment of materials | |
PL356853A1 (en) | Application of bacteriphages | |
GB0223254D0 (en) | Methods of treatment | |
GB0208783D0 (en) | Methods of treatment | |
GB0212821D0 (en) | Eyewash | |
GB0207139D0 (en) | Novel therapeutic treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |